Patents Assigned to Hackensack Meridian Health Center For Discovery and Innovation
  • Patent number: 11421194
    Abstract: The described invention provides an ex vivo dynamic multiple myeloma cancer niche contained in a pumpless perfusion culture device. The dynamic multiple myeloma cancer niche includes (a) a three-dimensional tissue construct containing a dynamic ex vivo bone marrow niche, which contains a mineralized bone-like tissue containing viable osteoblasts self-organized into cohesive multiple cell layers and an extracellular matrix secreted by the viable adherent osteoblasts; and a microenvironment dynamically perfused by nutrients and dissolved gas molecules; and (b) human myeloma cells seeded from a biospecimen composition comprising mononuclear cells and the multiple myeloma cells. The human myeloma cells are in contact with osteoblasts of the bone marrow niche, and the viability of the human myeloma cells is maintained by the multiple myeloma cancer niche.
    Type: Grant
    Filed: December 4, 2019
    Date of Patent: August 23, 2022
    Assignees: THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY, HACKENSACK MERIDIAN HEALTH CENTER FOR DISCOVERY AND INNOVATION
    Inventors: Woo Lee, Zhehuan Chen, Jenny Zilberberg
  • Publication number: 20220205990
    Abstract: A method of purifying Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER), designed for high-throughput analysis of low-abundance small-RNA cargos by next-generation sequencing, and use of this method for preparing purified populations of biological particles or cells from a biological sample for in vitro evaluation of a patient's risk of developing and for treating a severe viral infection; for enhancing therapeutic effectiveness of convalescent plasma therapy in a patient at risk for a severe coronavirus infection, and for treating a patient with a severe coronavirus infection, are described.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 30, 2022
    Applicant: HACKENSACK MERIDIAN HEALTH CENTER FOR DISCOVERY AND INNOVATION
    Inventors: Megan Irvette Mitchell, Olivier Loudig, Masood Kamali-Moghaddam
  • Publication number: 20200181551
    Abstract: The described invention provides an ex vivo dynamic multiple myeloma cancer niche contained in a pumpless perfusion culture device. The dynamic multiple myeloma cancer niche includes (a) a three-dimensional tissue construct containing a dynamic ex vivo bone marrow niche, which contains a mineralized bone-like tissue containing viable osteoblasts self-organized into cohesive multiple cell layers and an extracellular matrix secreted by the viable adherent osteoblasts; and a microenvironment dynamically perfused by nutrients and dissolved gas molecules; and (b) human myeloma cells seeded from a biospecimen composition comprising mononuclear cells and the multiple myeloma cells. The human myeloma cells are in contact with osteoblasts of the bone marrow niche, and the viability of the human myeloma cells is maintained by the multiple myeloma cancer niche.
    Type: Application
    Filed: December 4, 2019
    Publication date: June 11, 2020
    Applicants: Hackensack Meridian Health Center For Discovery and Innovation, The Trustees of the Stevens Institute of Technology
    Inventors: Woo LEE, Zhehuan CHEN, Jenny ZILBERBERG